Search research articles
Contact Us
Filters
Showing results (31-40 of 113) with videos related to
Page
of 12
Sort By:
Molecular Carcinogenesis
|
November 24, 2021
NUAK family kinase 2 is a novel therapeutic target for prostate cancer
Weiwei Fu, Megan T Zhao, Lucy M Driver, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Structure-activity Relationship for Diarylpyrazoles as Inhibitors of the Fungal Kinase Yck2
David J Shirley, Bonnie Yiu, Ikeer Mancera-Ortiz, et al.
Cell Chemical Biology
|
January 23, 2021
Development of a potent and selective chemical probe for the pleiotropic kinase CK2
Carrow I Wells, David H Drewry, Julie E Pickett, et al.
Scientific Reports
|
August 2, 2020
Synergistic drug combinations and machine learning for drug repurposing in chordoma
Edward Anderson, Tammy M Havener, Kimberley M Zorn, et al.
Scientific Reports
|
April 14, 2023
Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis
Frances M Bashore, Ariana B Marquez, Apirat Chaikuad, et al.
Chemmedchem
|
April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype
Christopher R M Asquith, Louisa Temme, Michael P East, et al.
ACS Chemical Biology
|
June 10, 2015
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
Hassan Al-Ali, Do-Hun Lee, Matt C Danzi, et al.
The Biochemical Journal
|
June 24, 2018
New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors
Dominic P Byrne, Yong Li, Pawin Ngamlert, et al.
Journal of Medicinal Chemistry
|
April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma
Christopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Oncology Letters
|
March 29, 2021
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells
Margarite D Matossian, Steven Elliott, Lyndsay V Rhodes, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 113) with videos related to
Sort By:
Page
of 12
Molecular Carcinogenesis
|
November 24, 2021
NUAK family kinase 2 is a novel therapeutic target for prostate cancer
Weiwei Fu, Megan T Zhao, Lucy M Driver, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Structure-activity Relationship for Diarylpyrazoles as Inhibitors of the Fungal Kinase Yck2
David J Shirley, Bonnie Yiu, Ikeer Mancera-Ortiz, et al.
Cell Chemical Biology
|
January 23, 2021
Development of a potent and selective chemical probe for the pleiotropic kinase CK2
Carrow I Wells, David H Drewry, Julie E Pickett, et al.
Scientific Reports
|
August 2, 2020
Synergistic drug combinations and machine learning for drug repurposing in chordoma
Edward Anderson, Tammy M Havener, Kimberley M Zorn, et al.
Scientific Reports
|
April 14, 2023
Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis
Frances M Bashore, Ariana B Marquez, Apirat Chaikuad, et al.
Chemmedchem
|
April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype
Christopher R M Asquith, Louisa Temme, Michael P East, et al.
ACS Chemical Biology
|
June 10, 2015
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
Hassan Al-Ali, Do-Hun Lee, Matt C Danzi, et al.
The Biochemical Journal
|
June 24, 2018
New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors
Dominic P Byrne, Yong Li, Pawin Ngamlert, et al.
Journal of Medicinal Chemistry
|
April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma
Christopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Oncology Letters
|
March 29, 2021
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells
Margarite D Matossian, Steven Elliott, Lyndsay V Rhodes, et al.
Page
of 12